Skip to main content
letter
. 2021 Nov 12;35(12):1189–1193. doi: 10.1007/s10822-021-00430-5

Table 1.

Factors to be considered before submission of a repurposing study

Is there experimental evidence to support the proposed mode of action and to validate any calculated data?

Present this experimental data explicitly

Distinguish carefully between measured and calculated data

Be careful to check cited references, to ensure they do contain experimental data and not in silico estimates
Is the mode of action specifically (target or pathway) or non-specifically (physicochemical property) driven?
Are the experimental activities significant? Cell-based assay: better than 1 microM
Biochemical assay, better than 100 nM
Virtual screening results on their own are not sufficient
Is there a clear causal link between the proposed mode of action and any clinical observations?
Can be it shown that the candidate should be safe and efficacious at established dosing protocols? Compare the concentrations required for effect at the target with the NOAEL and PK parameters